SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-036537
Filing Date
2022-06-13
Accepted
2022-06-13 20:59:57
Documents
2
Period of Report
2022-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4273
2 POA DOCUMENT poa.txt EX-24 2006
  Complete submission text file 0001209191-22-036537.txt   7680
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address
Stehman-Breen Catherine (Reporting) CIK: 0001702233 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40656 | Film No.: 221013239

Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Issuer) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)